1C0 fundamentals
CELYAD ONCOLOGY S.A. earnings per share and revenue
Report periodH2 2024
EPS estimate—
Revenue estimate—
H1 '20
H2 '20
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
−0.84
−0.63
−0.42
−0.21
0.00
H1 '20
H2 '20
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
0.00
11.00 K
22.00 K
33.00 K
44.00 K